The MD of Celesio UK, which is the parent company of Lloyds Pharmacy, is leaving the business with immediate effect just two weeks after it announced that it would be shutting or selling about 190 Lloyds branches.
Cormac Tobin departs after more than 10 years with the Celesio group where he has overseen three major acquisitions. Remaining members of the board will manage the business while a successor is sought.
In October Celesio said it was forced into the store closures after changes to government policy over the past two years gradually made many Lloyds stores unviable.
When asked whether Betterlife Healthcare, Lloyds’ mobility sister brand, will be affected by the closures, a spokesperson for Celesio UK told AMP that it is unable to confirm whether it will or won’t.
Brian Tyler, chairman of the management board of McKesson Europe, which owns Celesio UK, praised Tobin’s role in the group over the last decade.
“He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond. There is a genuine affection for him amongst our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.
“I am grateful for the dedication that Cormac has shown over the last few years and his leadership through an ever-changing external environment. I wish him every success for the future.”
Tyler added that he is confident that the group will be able to successfully navigate current and future challenges that the company faces.
Lloyds currently operates around 1,900 sites in the UK. It sells mobility aids such as scooters, wheelchairs and powerchairs, in addition to pharmaceuticals. Celesio also owns John Bell & Croyden which recently underwent a revamp which placed a new focus on its mobility arm.